Christos Kyprianou

Christos Kyprianou

Auto-generated profile, based on publicly available information

Christos Kyprianou

Mammalian Embryo and Stem Cell Group, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2017 in Science
Verified
Journal Article
Closed access
PDF file
SHSarah Ellys Harrison
Sarah Ellys Harrison
BSBerna Sozen
Berna Sozen
NCNeophytos Christodoulou
Neophytos Christodoulou
CKChristos Kyprianou
Christos Kyprianou
MZMagdalena Zernicka-Goetz
Magdalena Zernicka-Goetz
In vitro embryogenesis: Pluripotent embryonic stem cells (ESCs) can differentiate into any adult cell type; however, aggregates of these cells do not mimic embryonic architecture when grown in culture. To see whether mouse ESCs and their extraembryonic counterparts, trophoblast stem cells (TSCs), can recapitulate normal development, Harrison et al. combined ESCs and TSCs in an extracellular matrix culture (see the Perspective by Pera). The resultant “ETS-embryos” displayed considerable resemblance to normal embryos, even specifying mesoderm and primordial germ cells at the boundary between embryonic and extraembryonic compartments. These ETS-embryos are a genetically tractable tool for studying mammalian embryogenesis. Science , this issue p. eaal1810 ; see also p. 137

6 May 2020 in Nature
Verified
Journal Article
Closed access
PDF file
CKChristos Kyprianou
Christos Kyprianou
NCNeophytos Christodoulou
Neophytos Christodoulou
RHRussell Hamilton
Russell Hamilton
WNWallis Nahaboo
Wallis Nahaboo
DBDiana Suarez Boomgaard
Diana Suarez Boomgaard
MZMagdalena Zernicka-Goetz
Magdalena Zernicka-Goetz

15 October 2018 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
NCNeophytos Christodoulou
Neophytos Christodoulou
CKChristos Kyprianou
Christos Kyprianou
AWAntonia Weberling
Antonia Weberling
RWRan Wang
Ran Wang
GCGuizhong Cui
Guizhong Cui
MZMagdalena Zernicka-Goetz
Magdalena Zernicka-Goetz

12 October 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
DCDavid B. Chou
David B. Chou
BFBrooke A. Furlong
Brooke A. Furlong
RPRyan R. Posey
Ryan R. Posey
CKChristos Kyprianou
Christos Kyprianou
LOLucy R. O’sUllivan
Lucy R. O’sUllivan
DIDonald E Ingber
Donald E Ingber
Drug-induced cytopenias are a prevalent and significant issue that worsens clinical outcomes and hinders the effective treatment of cancer. While reductions in blood cell numbers are classically associated with traditional cytotoxic chemotherapies, they also occur with newer targeted small molecules and the factors that determine the hematotoxicity profiles of oncologic drugs are not fully understood. Here, we explore why some Aurora kinase inhibitors cause preferential neutropenia. By studying drug responses of healthy human hematopoietic cells in vitro and analyzing existing gene expression datasets, we provide evidence that the enhanced vulnerability of neutrophil-lineage cells to Aurora kinase inhibition is caused by early developmental changes in ATP-binding cassette (ABC) transporter expression. These data show that hematopoietic cell-intrinsic expression of ABC transporters may be an important factor that determines how some Aurora kinase inhibitors affect the bone marrow.

1 July 2020 in preLights
Verified
Preprint
Open access
CKChristos Kyprianou
Christos Kyprianou
A welcome message from the Community Manager -

1 July 2020 in preLights
Verified
Preprint
Open access
CKChristos Kyprianou
Christos Kyprianou
Advancing knowledge in mitochondria division using Dragonfly ultra-fast imaging -